Skip to content

D&A at other companies

Edwards Lifesciences logo
Edwards LifesciencesEW
$40.9M+11.7%
LeMaitre Vascular logo
LeMaitre VascularLMAT
$2.62M+2.8%
Medtronic logo
MedtronicMDT
$716M-14.8%
ITG
Integer HoldingsITGR
$35.01M+17.4%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$30.5M+4.1%
Boston Scientific logo
Boston ScientificBSX
$351M+8.0%

Other financials

Income statement

See full
Revenue$116.3M+17.5%
Gross profit$75.4M+18.7%
Operating income$5.8M+170%
Net income$1.4M+381%
EPS (diluted)$0.03+400%

Balance sheet

See full
Cash & equivalents$55.8M+47.9%
Total debt$258.2M-28.8%
Total equity$450.5M+53.1%
Total assets$883.2M+11.6%

Cash flow

See full
Operating cash flow$1.2M+107%
CapEx$8.0M+120%
Free cash flow-$6.8M+66.7%

Valuation

See full
Market cap$1.07B-24.8%
Enterprise value$1.27B-27.2%
P/E91.5×
P/S2.3×-1.3×

Profitability

See full
Gross margin64.6%+0.6pp
Operating margin8.2%+4.1pp
Net margin2.5%+1.5pp
FCF margin-0.1%-2.5pp

Returns & leverage

See full
Return on equity3.1%+1.8pp
Debt / equity0.6×-0.7×
Current ratio3.9×-1.7×

Where this comes from

Reported directly by Artivion in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Artivion’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Artivion's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Artivion's D&A?
Artivion (AORT) reported D&A of $6.34M in Q1 2026.
How has Artivion's D&A changed year-over-year?
Artivion's D&A increased by 16.4% year-over-year, from $5.45M to $6.34M.
What is the long-term trend for Artivion's D&A?
Over 4 years (2021 to 2025), Artivion's D&A has grown at a -1.6% compound annual growth rate (CAGR), from $23.98M to $22.46M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.